TrialBMC cancer2014

pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.

Steffen Ormanns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.